BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
Novo Nordisk (NJ) (NVO)To Launch Novoeight In The United States For People With Hemophilia A 3/26/2015
Egalet Provides Commercial Update On SPRIX And OXAYDO 3/25/2015
Eli Lilly (LLY) Release: First-In-Class Type 2 Diabetes Treatment Glyxambi (empagliflozin/Linagliptin) Tablets For Adults Now Available In U.S. Pharmacies 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Suneva Medical Introduces Regenica Recovery Gel 3/23/2015
NEOCUTIS Launches MICRO·ESSENTIALS™ Skincare Line Powered By MPC 3/23/2015
NeoStrata Company, Inc. Launches SKIN ACTIVE Dermal Replenishment 3/20/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Akorn, Inc. (AKN) Launches Phenylephrine HCl Ophthalmic Solution 3/20/2015
Emisphere Technologies, Inc. (EMIS) Launches Eligen B12, The First Oral Prescription Tablet Proven To Normalize B12 Levels Without The Need For An Injection 3/19/2015
Prestium Pharma, Inc. Announces Plans For Release Of Improved OLUX (Clobetasol Propionate) Foam 3/19/2015
Novogen Limited (NVGN) Release: Potential Of Anisina To Become Major New Chemotherapy Confirmed By Coda Study 3/18/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
TWi Pharmaceuticals, Inc. Announces The First Shipment Of Its Generic Product In The U.S. Market 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Allergan (AGN) Rival Ipsen (IPN.PA) to Continue U.S. Hiring Spree 3/16/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Merz North America Announces The Availability Of Radiesse (+) With Integral 0.3% Lidocaine 3/16/2015
FDA Rates Kitabis Pak As Therapeutic Equivalent Of TOBI 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Akorn, Inc. (AKN) Provides Update On Recent Product Launches 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Afaxys Pharmaceuticals Announces Launch Of Econtra EZ, Its First Over-The-Counter Emergency Contraceptive 3/11/2015
BioPharmX Announces Violet Iodine Now Available At Leading National Retailer 3/10/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
ANI Pharmaceuticals, Inc. Announces The Launch of Etodolac 200mg Capsules 3/10/2015
Colorcon, Inc. Introduces Opadry Amb II – The Next Advancement In Fully Formulated Film Coating Systems For Moisture Barrier Protection Of Pharmaceutical Tablets 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Genentech (RHHBY) Denies Knowledge of Distribution Problems for Cancer Drugs 3/9/2015
Manzo Pharmaceuticals Announces Progress, As Retail Stores Start To Carry Tummy Relief 3/9/2015
Larasan Pharmaceutical Corporation Release: FLEX24, New All-Natural Pain Reliever Lasts 24 Hours, Longer Than Other OTC Pain Relievers; Innovative Performance Tape A First In The Market 3/9/2015
AbbVie (ABBV) CEO Believes New Form of Humira Could Confront Generics 3/6/2015
Orexo US Launches New 8.6/2.1 Mg ZUBSOLV (Buprenorphine/Naloxone) Sublingual Tablet CIII: 8.6/2.1mg 3/6/2015
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey 3/5/2015
Akorn, Inc. (AKN) to Cease Use of its Drugs in Lethal Injections 3/4/2015
Elder Pharmaceutical Ltd. Forays Into The Rs 800 Crore Nasal Inhaler Segment With Launch Of "Solo" Inhalers 3/2/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Eisai Inc. (ESALF.PK) Release: LENVIMA (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo And Biologics, Inc. 2/27/2015
Pfizer (PFE) Release: CDC Advisory Committee On Immunization Practices Votes To Recommend Serogroup B Meningococcal Disease Vaccination For Persons At Increased Risk 2/26/2015
After Almost a Year Hiatus, GlaxoSmithKline (GSK)'s Popular Diet Pill alli Returns to Market 2/25/2015
Heritage Pharmaceuticals Initiates A Nationwide Voluntary Recall Of Colistimethate For Injection USP, 150 Mg And Rifampin For Injection USP, 600 Mg/Vial Due To A Lack Of Sterility Assurance 2/25/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Pre-Booking For Flublok Influenza Vaccine Now Available From Cardinal Health, Inc. (CAH) And McKesson Corporation 2/24/2015
Prometheon Pharma Release: Follicept Hair Growth Gel Set For Launch In 2015 By UF Transdermal Delivery Startup 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It? 2/23/2015
Tauriga Sciences Inc. (TAUG) Completes Manufacturing Of CannaCaviar CBD Soft Gels 2/23/2015
FDA Grants Seven Years’ Market Exclusivity To Eagle Pharmaceuticals (EGRX)’ Ryanodex For The Treatment Of Malignant Hyperthermia 2/23/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Actavis (ACT) Receives Final Approval For Generic Version Of Subutex 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Galderma Laboratories Announces Availability Of Soolantra® (ivermectin) Cream, 1% 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Actavis (ACT) Launches Generic Pulmicort RESPULES 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
SkinCeuticals Announces The Launch of Metacell Renewal B3 2/13/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Noven Pharmaceuticals Inc. Release: New Minivelle (Estradiol Transdermal System) 0.025 mg/day Dose Now Available by Prescription in U.S. Pharmacies 2/12/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
Aratana Therapeutics (PETX) Provides Product Updates 2/11/2015
BioLife Solutions, Inc. (BLFS.OB) Launches New Cell Thawing Media Products In Response To Worldwide Shortage Of Dextran Solutions 2/11/2015
Cumberland Pharmaceuticals (CPIX) Announces Pipeline Expansion With Boxaban (ifetroban) Oral Capsule 2/11/2015
Itonis Pharmaceuticals Distribution Of Its EMESYL(TM) Nausea Relief Seeking Marketing Evaluation To Air Infomercial With 2/11/2015
Itonis Pharmaceuticals's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins In Lodi, California 2/11/2015
Newly Approved Ibrance (Palbociclib) From Pfizer (PFE) Available Through Onco360 2/9/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Are You At Risk? Bayer HealthCare (BAY)'s Aspirin Launches The Proheart Path Tool To Assess CV Event Risk 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
AstraZeneca PLC (AZN) Release: MOVANTIK (naloxegol) Tablets Descheduled By The DEA 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Merck & Co. (MRK)’s Insomnia Medicine BELSOMRA® (Suvorexant) C-IV, The First And Only Orexin Receptor Antagonist, Now Available In The United States 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Inergetics, Inc. Completes Final Launch Preparations For Its New CBD-Based Pain Relief Supplement 2/3/2015
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge 2/2/2015
Vertex Pharmaceuticals (MA) (VRTX) Learns From Gilead Sciences, Inc. (GILD)'s Solvadi Mistakes as it Preps for CF Drug Launch 2/2/2015
FDA Approves New Dosing Option for CSL Behring's Hizentra® 2/2/2015
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015
Octapharma USA, Inc. Launches Co-Pay Assistance Program For Patients Receiving Wilate® 2/2/2015
ANI Pharmaceuticals, Inc. Announces The Launch Of Etodolac 300mg Capsules 1/30/2015
CytoSorbents, Inc. And Aferetica Introduce CytoSorb® To Italy 1/30/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
FDA Grants QIDP Designation To Neutrolin®, CorMedix (CRMD)'s Lead Product Candidate In The U.S. 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
Rhinomed (ASX:RNO) Release Of Next Generation Turbine Sports Technology 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut 1/27/2015
New England Biolabs Releases Rapid PNgase F For Biotherapeutic Development And Production 1/27/2015
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015
Purdue Pharma L.P. Release: Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available 1/26/2015
Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
After Gilead (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
Boehringer Ingelheim Pharmaceuticals, Inc. Release: SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available In The United States 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
IDEXX Laboratories, Inc. (IDXX) Announces SDMA As Important Expansion To Reference Lab Test Menu 1/19/2015
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/15/2015
Alimera Sciences (ALIM) Announces First Sale Of ILUVIEN® In Portugal 1/14/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas 1/13/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Gilead Sciences, Inc. (GILD) Throws Another Punch at AbbVie (ABBV) by Striking Deal With Anthem, Inc. 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
Perrigo Company (PRGO) Launches The Generic Version Of Clobex® (Clobetasol Propionate) Spray, 0.05% 1/12/2015
Perrigo Company (PRGO) Launches AB Therapeutic Equivalent Testosterone Gel 1.0% 1/12/2015
Life Extension Introduces Immune Senescense Protection Formula 1/12/2015
Afaxys Announces Nationwide Availability Of Tarina Fe 1/20 To The Public Health Sector, Colleges & Universities 1/12/2015
Bioo Scientific Corporation Releases 18S ITS rRNA Library Prep Kit To Simplify Eukaryotic Metagenomic Studies 1/9/2015
Impax Pharmaceuticals (IPXL) Announce FDA Approval Of RYTARY™ (Carbidopa And Levodopa) Extended-Release Capsules For The Treatment Of Parkinson's Disease 1/8/2015
Gilead Sciences, Inc. (GILD) Fights Back as CVS Will Exclusively Cover Hepatitis C Drug Harvoni 1/7/2015
Lyophilization Services of New England Receives Approval To Manufacture Commercial Aseptic Product 1/7/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Fresenius Kabi AG Introduces NAROPIN® In Freeflex® Bag 1/6/2015
Lupin Ltd. (LUPN.BO) Launches Generic DIOVAN® Tablets 1/6/2015
Mylan Inc. (MYL) Launches Generic Diovan® Tablets 1/5/2015
NovaBay Pharmaceuticals, Inc. (NBY) Rebrands Its i-Lid Cleanser As Avenova 1/5/2015
Galderma Laboratories Launches Its First Over-The-Counter Acne Regimen, Benzac® Acne Solutions 1/5/2015
Newly-Approved Keryx Biopharmaceuticals (KERX) Drug Poised to Take About $600 Million of Genzyme Corporation (GENZ)'s Sales 1/2/2015
Sagent Pharmaceuticals, Inc. Announces The Launch Of Colistimethate For Injection, USP 12/30/2014
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD) 12/24/2014
PuraMed BioScience Nears Final Stages Needed For Distribution Of MigraPure H 12/23/2014
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States 12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Mylan Inc. (MYL) Launches First Generic Version Of Vivelle-DOT® 12/22/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag 12/19/2014
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014
NVN Therapeutics Launches Estracool™ Dietary Supplement For Reduction Of Menopausal Symptoms 12/18/2014
Putney, Inc. Launches Carprofen Chewable Tablets 12/18/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Valganciclovir Tablets, USP 12/16/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Pacira Pharmaceuticals, Inc. (PCRX) Announces Changes To EXPAREL® Label 12/12/2014
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants 12/11/2014
Abbott Laboratories (ABT)'s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe 12/11/2014
Mylan Inc. (MYL) Launches First Generic Version Of Orapred ODT 12/11/2014
Mylan Inc. (MYL) Launches Generic Robaxin Injection 12/11/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Mylan Inc. (MYL) Launches One Of First Available Generic Versions Of Celebrex Capsules 12/10/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada 12/9/2014
BioPharmX Corporation Release: Introducing Violet Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* 12/9/2014
ConvaTec Introduces Sensi-Care Clear Zinc Skin Protectant For Diaper Rash 12/9/2014
Ignyta (RXDX) Receives Approval Of Nonproprietary Name Entrectinib For Lead Product Candidate, RXDX-101 12/9/2014
BioPharmX Corporation Release: Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort 12/9/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
PTC Therapeutics, Inc. (PTCT) Announces Launch Of Translarna (ataluren) In Germany 12/3/2014
Galderma Laboratories, L.P. Release: The Cetaphil® Brand Launches New Cetaphil® Baby Line 12/3/2014
Suneva Medical Release: Bellafill To Replace ArteFill As New Brand 12/2/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Pfanstiehl Laboratories Launches cGMP-Produced, Parenteral Grade Mannitol For Pharmaceutical Formulations 12/2/2014
Catylix And Aspira Scientific Launch The First Reagent For Pentafluoroethylation 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
FDA Warning: PML Death Associated With Biogen Idec (BIIB)'s Tecfidera 11/26/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Pfizer (PFE) Release: TRUMENBA® (Meningococcal Group B Vaccine) Is Now Available 11/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014
Organovo Announces Commercial Release Of The exVive3D™ Human Liver Tissue 11/18/2014
Peli Biothermal Coolpall Vertos Launch Success In Europe 11/18/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
Galderma Laboratories Release: The Cetaphil® Brand Revamps RestoraDerm® Product Line 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Kremers Urban Pharmaceuticals Inc. Informed By U.S. FDA Of ANDA Reclassification Of Methylphenidate ER 11/14/2014
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014